Acute kidney injury does not predict worsening kidney function trajectory in CKD patients

FHS
July 11, 2023
12:09 am

A study of hospitalized persons with chronic kidney disease (CKD) fournd that acute kidney injury (AKI) did not predict worsening of kidney function trajectory once difference in pre-hospitalization characteristically were fully accounted for.

Amgen touts new data for drug MariTide, moving rapidly into Phase 3 work

Amgen said that an interim look at a Phase 2 trial of its anti-obesity drug MariTide had left the company “very encouraged,” and it planned

May 3, 2024

FDA accepts Mesoblast’s latest BLA for paediatric GvHD cell therapy – Pharmaceutical Technology

Remestemcel-L is a stem cell therapy developed with the mesenchymal stem cells (MSC) derived from the bone marrow of an unrelated donor. Credits: ArtemisDiana/Shutterstock.com Mesoblast

July 23, 2024

Eckert & Ziegler opens new facilities for radiopharmaceutical plant engineering in Dresden – Biotech Investments

EQS-News: Eckert & Ziegler SE / Key word(s): Expansion/Miscellaneous Eckert & Ziegler opens new facilities for radiopharmaceutical plant engineering in Dresden 20.08.2024 / 17:00 CET/CEST

August 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.